Full-Time

Field Clinical Specialist

Peripheral Vascular

Updated on 7/21/2026

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

Compensation Overview

$130k/yr

+ Commission + Bonus

Company Historically Provides H1B Sponsorship

Cincinnati, OH, USA

In Person

Based in Cincinnati, Ohio; travel up to 80% locally and regionally.

Category
Medical, Clinical & Veterinary (1)

Get referred to Stryker

Find people who can refer or advise you

Requirements
  • Associates degree in nursing or related clinical discipline preferred.
  • Minimum three (3) years of equivalent combination of education, training, and hands-on experience in a cath lab, nursing, or comparable clinical environment.
  • Proven understanding of cardiovascular science, cardiovascular anatomy, pathology and physiology
  • Strong clinical acumen is required.
  • Travel up to 80% of the time – both locally and regionally, and occasionally overnight.
  • Night/weekend on call per preplanned scheduled.
  • Extensive sitting, standing, and speaking.
  • Light lifting to 10 pounds.
  • Must be open to a dynamic work environment which includes regular interaction with several different physician and hospital staff customers in several locations.
  • Must have desire to participate in a healthcare team in the treatment of patients and anticipate needs of others.
  • Apply critical thinking skills to solve complex clinical problems.
  • Excellent command of the English language with comprehensive written and verbal communication, interpersonal, analytical, and organizational skills.
  • Must have the ability to concentrate on detail and work independently and meet deadlines with strong attention to detail
  • Comprehensive computer skills with experience in Microsoft Office with ability to develop presentation materials.
Responsibilities
  • Educate physicians on device handling, implantation and troubleshooting techniques related to Inari products.
  • Develop, lead and/or facilitate training sessions and in-service education programs in the hospital environment.
  • Identify therapy adoption opportunities in collaboration with Regional and Account Managers in local geographies.
  • Communicate highly technical information clearly and effectively during fast-paced procedures.
  • Act as a clinical interface between the medical community and the Company.
  • Demonstrate ability to build and sustain credible business relationships with customers and share product expertise accordingly.
  • Provide education and clinical support in response to the most complex field inquiries on an as-needed basis.
  • Demonstrate a thorough understanding of all Inari products, related products and technical knowledge, trends, and players.
  • Collaborate with product development teams to provide feedback on device features and new device development
  • Document procedural case observations for regulatory requirements and ongoing continuous improvement
  • Other duties as needed.
Desired Qualifications
  • Understanding of sales process is a plus.
  • Comprehensive computer skills with experience in Microsoft Office with ability to develop presentation materials

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Vascular division jumped 27.5% following Inari acquisition, boosting organic growth outlook.
  • Trident II Acetabular System launched in India, targeting rising hip replacement demand from aging populations.
  • Free cash flow rose 227% to $415 million, strengthening capital efficiency and investor returns.

What critics are saying

  • March 11, 2026 cyberattack by Handala disrupted global manufacturing, causing high-impact Q1 earnings miss.
  • BofA cut price target to $380 on medtech slowdown, reducing 2027 earnings estimates due to soft utilization.
  • Intuitive Surgical's 39x earnings vs Stryker's 22x risks valuation erosion in joint-replacement markets.

What makes Stryker unique

  • Pangea Plating System launched in Europe on May 26, 2026, addressing diverse fractures without plate bending.
  • Mako-driven orthopaedics franchise grows with integrated robotics for total joint and trauma procedures.
  • TPX HD power tool delivers 296% more torque for demanding orthopaedic revision surgeries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.